Gracell Biotechnologies Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q2 2023

Taxonomy & unit
us-gaap: CNY and USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Gracell Biotechnologies Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q2 2023.
  • Gracell Biotechnologies Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2023 was $1.78M, a 46.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $1.78M -$1.53M -46.3% Jun 30, 2023 6-K 2023-08-14
Q4 2022 $3.12M -$1.53M -32.9% Dec 31, 2022 20-F 2023-04-25
Q2 2022 $3.31M Jun 30, 2022 6-K 2022-08-15
Q4 2021 $4.65M Dec 31, 2021 20-F 2022-04-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.